Ezetimibe, commonly known by the brand name Ezetrol, is a medication specifically designed to reduce the absorption of cholesterol from the small intestine. Unlike statins, which work in the liver by inhibiting cholesterol production, Ezetimibe directly targets dietary and biliary cholesterol uptake in the gastrointestinal tract. By reducing overall cholesterol influx into the bloodstream, it helps lower harmful LDL levels and can be used in combination with statins or on its own if statins are not tolerated.<\/p>\n
The primary advantage of Ezetimibe is its complementary mechanism of action, which can lead to an additional decrease in LDL cholesterol levels when added to a statin regimen. For many patients, this combination approach optimizes lipid control without significantly increasing side-effect risk. Ezetimibe is generally well tolerated, though some individuals may experience mild gastrointestinal symptoms or fatigue.<\/p>\n
Beyond lowering LDL, Ezetimibe may provide a modest effect on total cholesterol and triglycerides. Healthcare providers often recommend its use alongside lifestyle measures such as a balanced diet, regular exercise, and weight management for individuals at risk of atherosclerotic cardiovascular disease.<\/p>\n
Regular monitoring of lipid profiles helps track progress, ensuring that patients achieve their personalized cholesterol goals. Ezetimibe\u2019s once-daily dosing can enhance adherence, which is an important factor in effective long-term management of dyslipidemia.<\/p>\n","protected":false},"excerpt":{"rendered":"